A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite System
Completed · Phase 4 · NCT07122583
Conditions: Non-Surgical Fat Reduction
At a glance
- Research payments reported, 2025
- $298,876
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 102
About the trial
- Sponsor
- AbbVie
- Tested
- CoolSculpting Elite System (device)
- Dates
- Started 2025-07-22; completion 2026-06-03
- Results posted
- Not yet
The primary objective of this protocol is the continued collection of data specific to the submental, inner thigh and back/bra body areas with CoolSculpting Elite. The study aims to collect post-market safety data while allowing for the collection of standardized photos and satisfaction questionnaires after treatment with commercial treatment parameters.
From ClinicalTrials.gov, last updated 2026-07-02. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $298,876 in research payments for this study in 2025 (13 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Brenda M. Latowsky, MD Dermatology · Scottsdale, AZ
- Suzanne L. Kilmer, MD Dermatology · Sacramento, CA
- Amir Moradi, MD ENT (Otolaryngology) · Vista, CA
- Terrence C. Keaney, M.D Dermatology · Washington, DC
- Sue Ellen Cox, M.D. Dermatology · Chapel Hill, NC
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Pacific Clinical Innovations Inc $107,410
- Laser & Skin Surgery Medical $70,919
- Skin Dc PLLC $65,945
- Investigate MD LLC $44,603
- Aesthetic Solutions Msp PA $10,000
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.